{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:10:44Z","timestamp":1779160244245,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070747"],"award-info":[{"award-number":["82070747"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.intimp.2021.107875","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T01:41:47Z","timestamp":1623894107000},"page":"107875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Crystalline appearance in light chain cast nephropathy is associated with higher early mortality in patients with newly diagnosed multiple myeloma"],"prefix":"10.1016","volume":"98","author":[{"given":"Zi-Shan","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Juan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-De","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107875_b0005","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.2215\/CJN.02560316","article-title":"American society of nephrology onco-nephrology F. Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-what determines the site of injury?","volume":"11","author":"Doshi","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrology: CJASN"},{"key":"10.1016\/j.intimp.2021.107875_b0010","doi-asserted-by":"crossref","DOI":"10.1007\/s40620-020-00926-7","article-title":"A non-invasive differential diagnostic model for light chain cast nephropathy in newly diagnosed multiple myeloma patients with renal involvement: a multicenter study","author":"Lin","year":"2021","journal-title":"J. Nephrology"},{"key":"10.1016\/j.intimp.2021.107875_b0015","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.2147\/CMAR.S301818","article-title":"Monoclonal immunoglobulin-associated renal lesions in patients with newly diagnosed multiple myeloma: a report from a single center","volume":"13","author":"Lin","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.intimp.2021.107875_b0020","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/ajh.25959","article-title":"Clinically-suspected cast nephropathy: A retrospective, national, real-world study","volume":"95","author":"Szabo","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.intimp.2021.107875_b0025","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1182\/blood.2019003807","article-title":"Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study","volume":"135","author":"Royal","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2021.107875_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ekir.2020.06.026","article-title":"Multiple myeloma-associated ig light chain crystalline cast nephropathy","author":"Matsumura","year":"2020","journal-title":"Kidney International Reports"},{"key":"10.1016\/j.intimp.2021.107875_b0035","article-title":"Crystalline light chain cast nephropathy in multiple myeloma","author":"Lin","year":"2020","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.intimp.2021.107875_b0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5414\/CN109770","article-title":"Coincidental crystalline light chain cast nephropathy, light chain proximal tubulopathy, and urine crystallopathy: A case report and review of the literature","volume":"93","author":"Lerner","year":"2020","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.intimp.2021.107875_b0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5414\/CN108424","article-title":"Light chain crystalline kidney disease: diagnostic urine microscopy as the \u201cliquid kidney biopsy\u201d","volume":"82","author":"Luciano","year":"2014","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.intimp.2021.107875_b0050","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.intimp.2021.107875_b0055","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J. Clin. Oncology : Official J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.intimp.2021.107875_b0060","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International Myeloma Working G. International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.intimp.2021.107875_b0065","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1200\/JCO.20.00298","article-title":"Randomized trial comparing double versus triple bortezomib-based regimen in patients with multiple myeloma and acute kidney injury due to cast nephropathy","volume":"38","author":"Bridoux","year":"2020","journal-title":"J. Clin. Oncology : Official J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.intimp.2021.107875_b0070","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/ajh.24796","article-title":"Recognition of early mortality in multiple myeloma by a prediction matrix","volume":"92","author":"Terebelo","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.intimp.2021.107875_b0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40620-018-0492-4","article-title":"Myeloma light chain cast nephropathy, a review","volume":"32","author":"Sathick","year":"2019","journal-title":"J. Nephrology"},{"key":"10.1016\/j.intimp.2021.107875_b0080","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/ki.1995.421","article-title":"Acute myeloma kidney","volume":"48","author":"Winearls","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2021.107875_b0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1034\/j.1600-0609.2000.90221.x","article-title":"Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group","volume":"65","author":"Knudsen","year":"2000","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.intimp.2021.107875_b0090","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1681\/ASN.2014090876","article-title":"ESRD due to Multiple Myeloma in the United States, 2001\u20132010","volume":"27","author":"Reule","year":"2016","journal-title":"J. Am. Soc. Nephrology: JASN"},{"key":"10.1016\/j.intimp.2021.107875_b0095","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1172\/JCI119218","article-title":"Localization of a single binding site for immunoglobulin light chains on human Tamm-Horsfall glycoprotein","volume":"99","author":"Huang","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2021.107875_b0100","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/modpathol.2017.124","article-title":"Intratubular amyloid in light chain cast nephropathy is a risk factor for systemic light chain amyloidosis","volume":"31","author":"Gibier","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.intimp.2021.107875_b0105","first-page":"398","article-title":"Crystal nephropathy: a variant form of myeloma kidney\u2013a case report and review of the literature","volume":"56","author":"Kanno","year":"2001","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.intimp.2021.107875_b0110","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1093\/ndt\/gfr377","article-title":"Acute renal failure with lambda light chain-derived crystals in a patient with IgD myeloma","volume":"26","author":"Toly-Ndour","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2021.107875_b0115","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1440-1797.2005.00499.x","article-title":"Multiple myeloma-associated cast nephropathy with crystal structure: case report and review of the literature","volume":"10","author":"Chen","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.intimp.2021.107875_b0120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/0886022X.2013.844643","article-title":"Acute kidney injury due to tubular intraluminal monoclonal light chain crystals mimicking acute pyelonephritis","volume":"36","author":"Haider","year":"2014","journal-title":"Ren. Fail."},{"key":"10.1016\/j.intimp.2021.107875_b0125","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ekir.2016.08.005","article-title":"Lambda light chain crystalline cast nephropathy and proximal tubulopathy","volume":"1","author":"Gallan","year":"2016","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.intimp.2021.107875_b0130","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10157-015-1187-y","article-title":"Crystalline cast nephropathy in a patient with IgD lambda myeloma","volume":"20","author":"Kumakura","year":"2016","journal-title":"Clin. Exp. Nephrology"},{"key":"10.1016\/j.intimp.2021.107875_b0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1440-1827.1996.tb03594.x","article-title":"Crystalglobulin-induced vasculopathy accompanying ischemic intestinal lesions of a patient with myeloma","volume":"46","author":"Usuda","year":"1996","journal-title":"Pathol. Int."},{"key":"10.1016\/j.intimp.2021.107875_b0140","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrneph.2017.10","article-title":"Crystal nephropathies: mechanisms of crystal-induced kidney injury","volume":"13","author":"Mulay","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2021.107875_b0145","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1681\/ASN.2017121319","article-title":"The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases","volume":"29","author":"Sethi","year":"2018","journal-title":"J. Am. Soc. Nephrology : JASN"},{"key":"10.1016\/j.intimp.2021.107875_b0150","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","article-title":"International myeloma working group recommendations for the diagnosis and management of myeloma-related renal impairment","volume":"34","author":"Dimopoulos","year":"2016","journal-title":"J. Clin. Oncology : Official J. Am. Soc. Clin. Oncology"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:43:08Z","timestamp":1762551788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921005117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":30,"alternative-id":["S1567576921005117"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107875","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crystalline appearance in light chain cast nephropathy is associated with higher early mortality in patients with newly diagnosed multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107875"}}